FDA Inspection 1342764 — Joseph Caporusso, DPM
The FDA completed an inspection of Joseph Caporusso, DPM on Oct 22, 2026 in Mcallen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 22, 2026
- Fiscal Year
- 2027
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mcallen, TX (United States)